149 related articles for article (PubMed ID: 37882962)
1. Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy.
Liu Z; Wan C; Cao Y; Liu S; Xu Z; Zhang C; Su H
J Nephrol; 2024 Jan; 37(1):149-158. PubMed ID: 37882962
[TBL] [Abstract][Full Text] [Related]
2. Lupus-like membranous nephropathy during the postpartum period expressing glomerular antigens exostosin 1/exostosin 2 and phospholipase A2 receptor: a case report.
Miyasaka R; Wada Y; Takeuchi K; Abe T; Uchitsubo R; Kawamura S; Sakurabayashi S; Naito S; Aoyama T; Shimizu A; Takeuchi Y
CEN Case Rep; 2024 Jan; ():. PubMed ID: 38280123
[TBL] [Abstract][Full Text] [Related]
3. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
Sethi S; Madden BJ; Debiec H; Charlesworth MC; Gross L; Ravindran A; Hummel AM; Specks U; Fervenza FC; Ronco P
J Am Soc Nephrol; 2019 Jun; 30(6):1123-1136. PubMed ID: 31061139
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Characteristics and Outcomes of PLA
Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
[TBL] [Abstract][Full Text] [Related]
5. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
6. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy.
Ye T; Jiang M; Zeng X; Zong D; Du Y; Li X; Huang B; Tang X
Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38154829
[TBL] [Abstract][Full Text] [Related]
8. In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes.
Ravindran A; Casal Moura M; Fervenza FC; Nasr SH; Alexander MP; Fidler ME; Herrera Hernandez LP; Zhang P; Grande JP; Cornell LD; Gross LA; Negron V; Jenson GE; Madden BJ; Charlesworth MC; Sethi S
J Am Soc Nephrol; 2021 Mar; 32(3):695-706. PubMed ID: 33478971
[TBL] [Abstract][Full Text] [Related]
9. Primary Membranous Nephropathy With Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases.
Iwakura T; Ema C; Sato T; Isobe S; Fujikura T; Ohashi N; Kato A; Yasuda H
Kidney Med; 2021; 3(4):669-673. PubMed ID: 34401734
[TBL] [Abstract][Full Text] [Related]
10. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
[TBL] [Abstract][Full Text] [Related]
11. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.
Hayashi N; Akiyama S; Okuyama H; Matsui Y; Adachi H; Yamaya H; Maruyama S; Imai E; Matsuo S; Yokoyama H
Clin Exp Nephrol; 2015 Oct; 19(5):797-803. PubMed ID: 25492250
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies.
Li X; Shen Y; Li Y; Ma L; Sun Q
Ren Fail; 2024 Dec; 46(1):2297015. PubMed ID: 38275176
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of glomerular C1q deposits in primary MN.
Zhang MF; Cui Z; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Liu G; Zhao MH
Clin Chim Acta; 2018 Oct; 485():152-157. PubMed ID: 29969623
[TBL] [Abstract][Full Text] [Related]
15. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A
Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406
[TBL] [Abstract][Full Text] [Related]
16. [C1q or IgA deposition in glomeruli of children with primary membranous nephropathy].
Xu K; Wang F; Wang ZH; Sun LY; Yao Y; Xiao HJ; Liu XY; Su BG; Zhong XH; Guan N; Zhang HW; Ding J
Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):901-907. PubMed ID: 36038299
[No Abstract] [Full Text] [Related]
17. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
Hu R; Xing G; Wu H; Zhang Z
Diagn Pathol; 2016 Sep; 11(1):86. PubMed ID: 27624606
[TBL] [Abstract][Full Text] [Related]
18. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
[TBL] [Abstract][Full Text] [Related]
19. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor.
Debiec H; Hanoy M; Francois A; Guerrot D; Ferlicot S; Johanet C; Aucouturier P; Godin M; Ronco P
J Am Soc Nephrol; 2012 Dec; 23(12):1949-54. PubMed ID: 23123401
[TBL] [Abstract][Full Text] [Related]
20. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
